Aortic valve replacement in patients over 60: Real-world surgical outcomes.

Anoop S Sumal Jason M Ali Harry Kyriacou Christopher J TuttleNarain Moorjani

Published in: Journal of cardiac surgery (2021)

SAVR can be performed in patients ≥60 years old with excellent outcomes, which compare favorably with outcomes from TAVI trials, with their highly selected patient cohorts. SAVR remains a reliable, tried and tested, treatment option in these patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
aortic valve replacement
prognostic factors
type diabetes
patient reported outcomes
coronary artery disease
insulin resistance
metabolic syndrome
skeletal muscle
atrial fibrillation
weight loss
patient reported